Research / Clinical Summary

Douglas Richman, MD Professor IR, Pathology / Medicine Tumor Growth, Invasion & Metastasis Program Contact by Email Visit the Website

Dr. Richman trained in infectious diseases and medical virology with research on influenza virus, herpesviruses and hemorrhagic fever viruses before focusing on HIV in the 1980s. HIV drug resistance was originally recognized in his laboratory in 1988. In addition to his continuing interest in HIV treatment and drug resistance, his research interests have focused on HIV pathogenesis including the issues of viral latency and evolution. He is a Fellow of the American Association for the Advancement of Science, the American Association of Physicians and the Infectious Disease Society of America. He is a member of the NIH AIDS Vaccine Research Committee.

Update Summary via ONcLINE (password required)
Click here to request a new or forgotten password